Pfizer / Biontech has announced that its vaccine is 100% effective in the age group between 12 and 15 years.
The Pfizer / BioNTech coronavirus vaccine is 100% effective in adolescents aged 12 to 15, according to the results of a clinical trial.
The two pharmaceutical companies hope they can start vaccinating this age group before the start of the next school year.
The tests, which involved 2,260 teenagers in the United States, "showed 100% efficacy and potent antibody responses," Pfizer and BioNTech said in a statement announcing that they will ask regulatory authorities for approval of the drug for adolescents. .
